Characteristic | MSC | Tumor cells | References |
---|---|---|---|
Cell Division | Controlled | Uncontrolled | [5, 7, 111] |
MHC I expression | + | Variable | Fig 2 & [25, 27, 28, 39, 93, 111, 112] |
MHC II expression | - | Variable | Fig 2 & [2, 25, 27, 39, 93, 111, 112] |
CD80 expression | - | - | [25, 28, 39, 44, 94, 95] |
CD86 expression | - | - | Fig 2 & [25, 28, 39, 44, 94, 95] |
FasL expression | - | + | Fig. 2 & [102-104] |
Prostaglandin secretion | + | + | [21, 28, 82, 100] |
IDO expression | + | Variable | [28, 43, 59, 87, 90] |
TGF-β secretion | Variable | + | [42, 43, 59, 101, 105] |
IL-10 secretion | + | + | [13, 42, 72, 100] |
DC modulation | + | + | [24, 26, 42, 96] |
Veto effects on T cells | + | + | [23, 112] |